RAPT Therapeutics

General Information


We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary drug discovery and development engine, we are developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases.

Employees: 94
Founded: 2015
Contact Information
Address 561 Eccles Avenue South San Francisco, CA 94080, US
Phone Number (650) 489-9000
Web Address http://www.rapt.com
View Prospectus: RAPT Therapeutics
Financial Information
Market Cap $255.3mil
Revenues $0 mil (last 12 months)
Net Income $-39.5 mil (last 12 months)
IPO Profile
Symbol RAPT
Exchange NASDAQ
Shares (millions): 3.0
Price range $12.00 - $12.00
Est. $ Volume $36.0 mil
Manager / Joint Managers BMO Capital Markets/ Wells Fargo Securities/ UBS Investment Bank
CO-Managers -
Expected To Trade: 10/31/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change